Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials

Fig. 3

Kaplan-Meier plots of primary end point achievement in the EPPIC-USA population. a ITT primary end point censored at last contact, b PP primary end point censored at last contact, c PP ESRD censored at last contact, d ITT DN primary end point censored at last contact, e PP DN primary end point censored at last contact, f PP DN ESRD censored at last contact. DN diabetic nephropathy, ESRD end stage renal disease, ITT intent-to-treat, PP per protocol

Back to article page